Proton PBS reduces low-dose lung exposure but raises robustness concerns in central SBRT
In ten central lung tumors, proton PBS reduced low-dose lung exposure versus VMAT, but some critical-organ doses were less robust.
In ten central lung tumors, proton PBS reduced low-dose lung exposure versus VMAT, but some critical-organ doses were less robust.
In mouse models, loss of bronchiolar club cells increased mortality after thoracic irradiation and disrupted epithelial repair following focal lung exposure.
In 414 lung cancer patients, deep-learning dose features modestly improved external prediction estimates, but discrimination gains were not statistically significant.
In 60 selected patients, radical thoracic reirradiation produced 17% grade 3 toxicity and no grade 4–5 events over 26.5 months.
In 115 peripheral lung SBRT patients, five-year survival was 36% for left-sided lesions versus 70% for right-sided lesions, an exploratory association.
In 280 patients receiving palliative thoracic RT, CT-detected airway obstruction was associated with 2.6-fold higher adjusted odds of clinical airway events.
Within 41 lung cancer patients, lower thoracic lymph nodes moved 5.2 versus 3.3 mm cranio-caudally, challenging uniform internal margins.
In 18 evaluable patients, papaverine combined with lung SBRT achieved 100% estimated two-year local control, with two dose-limiting toxicities.
New ESTRO–ReCOG guidance recommends validated cumulative dose assessment and daily volumetric image guidance, prioritizing critical organs during lung reirradiation.
Contrast-enhanced CT altered mean lung electron density by approximately 12–13%, but bulk-density MR-Linac dose recalculations showed relatively small differences.
Blocking type I interferon signaling reduced inflammation and fibrosis after focal lung irradiation in mice by limiting ILC2-to-ILC1 plasticity.
In 25 peripheral lung SBRT plans, PlanIQ classified 68% of achieved V20 values as theoretically impossible under standard reference-dose settings.
A two-variable NTCP model predicted grade ≥2 acute esophageal toxicity with AUC 0.75 and was incorporated into Dutch proton selection criteria.
After immune checkpoint inhibitor exposure, higher EQD2-adjusted lung dose and shorter intervals before thoracic RT were associated with symptomatic pneumonitis.
Normal-lung CT response was partly reproducible across RT courses, while short retreatment intervals increased response in previously irradiated lung.